返回
NovaBay Pharmaceuticals Inc（NBY）價格
NBY 股價走勢圖
NBY 收益
NovaBay Pharmaceuticals Inc
$5.87
-9.69%
$-0.62
收盤價：Jan 21, 16:00:00 GMT-5
$5.9
0.51%
$0.03
盤後：Jan 21, 16:19:51 GMT-5
最新獲利結果： Q3 '24
報導： 2024-11-07
歷史收益
每季
年度
EPS
收入
Earnings FAQ
NBY 最近的每股盈餘與預期相比如何？
NovaBay Pharmaceuticals Inc NBY 上一季度的收入表現如何？
NovaBay Pharmaceuticals Inc 的收入預期是多少？
NovaBay Pharmaceuticals Inc 的盈利品質評分是多少？
NovaBay Pharmaceuticals Inc 何時發布財報？
NovaBay Pharmaceuticals Inc 的預期收益是多少？
NovaBay Pharmaceuticals Inc 是否超出收益預期？
關鍵數據
前收市價
$6.5
開盤價
$6.3
當日範圍
$5.51 - $6.35
52週區間
$0.46 - $19.95
交易量
2.0M
平均成交量
1.2M
每股盈餘 (TTM)
-6.62
股息收益率
--
市值
$743.4M
什麼是 NBY？
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.